The United States leads in mortality from musculoskeletal and connective tissue diseases, with Japan and Germany following. Notably, the U.S. experienced a 3.2% increase, while Germany saw a 4.94% rise. Contrastingly, the United Kingdom and South Korea witnessed declines. Colombia had a significant 6.89% decrease, whereas smaller countries like Iceland saw minor growth. Costa Rica showed substantial growth while European countries like Finland, Luxembourg, and Slovakia saw declines, indicating regional disparities.
Future trends to watch include technological advancements and healthcare access improvements potentially reducing mortality rates. Attention on aging populations, particularly in developed nations, is also essential for forecasting healthcare needs related to musculoskeletal diseases.
Top countries in Musculoskeletal System and Connective Tissue Diseases Mortality by Country
| # | 10 Countries | Units (Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 16,140 | 2023 | +1.5% | +3.2% | View data |
| 2 | 2 Japan | 9,930 | 2023 | +3.21% | +2.43% | View data |
| 3 | 3 Germany | 6,630 | 2023 | +4.75% | +4.94% | View data |
| 4 | 4 Mexico | 5,580 | 2023 | +1.16% | +2.98% | View data |
| 5 | 5 Spain | 5,240 | 2023 | +1.12% | +0.12% | View data |
| 6 | 6 United Kingdom | 4,230 | 2023 | +0.095% | -0.66% | View data |
| 7 | 7 Canada | 2,180 | 2023 | +1.68% | +2.07% | View data |
| 8 | 8 South Africa | 2,130 | 2023 | +1.28% | +0.82% | View data |
| 9 | 9 Colombia | 1,650 | 2023 | -2.65% | -6.89% | View data |
| 10 | 10 Australia | 1,540 | 2023 | +1.85% | +2.84% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
